Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Gene replacement ameliorates deficits in mouse and human models of cyclin-dependent kinase-like 5 disorder.

Gao Y, Irvine EE, Eleftheriadou I, Naranjo CJ, Hearn-Yeates F, Bosch L, Glegola JA, Murdoch L, Czerniak A, Meloni I, Renieri A, Kinali M, Mazarakis ND.

Brain. 2020 Mar 1;143(3):811-832. doi: 10.1093/brain/awaa028.

PMID:
32125365
2.

Association of Circulating Osteopontin Levels With Lower Extremity Arterial Disease in Subjects With Type 2 Diabetes Mellitus: A Cross-Sectional Observational Study.

Eleftheriadou I, Tsilingiris D, Tentolouris A, Mourouzis I, Grigoropoulou P, Kapelios C, Pantos C, Makrilakis K, Tentolouris N.

Int J Low Extrem Wounds. 2020 Feb 11:1534734619898097. doi: 10.1177/1534734619898097. [Epub ahead of print]

PMID:
32041444
3.

Endothelial progenitor cells and peripheral neuropathy in subjects with type 2 diabetes mellitus.

Eleftheriadou I, Dimitrakopoulou N, Kafasi N, Tentolouris A, Dimitrakopoulou A, Anastasiou IA, Mourouzis I, Jude E, Tentolouris N.

J Diabetes Complications. 2020 Apr;34(4):107517. doi: 10.1016/j.jdiacomp.2019.107517. Epub 2020 Jan 7.

PMID:
31928893
4.

Carbohydrate restriction in the morning increases weight loss effect of a hypocaloric Mediterranean type diet: a randomized, parallel group dietary intervention in overweight and obese subjects.

Dellis D, Tsilingiris D, Eleftheriadou I, Tentolouris A, Sfikakis PP Jr, Dellis G, Karanasiou M, Meimari A, Dimosthenopoulos C, Lazarou S, Tentolouris N.

Nutrition. 2020 Mar;71:110578. doi: 10.1016/j.nut.2019.110578. Epub 2019 Sep 5.

PMID:
31838462
5.

Improvement of metabolic control after 3-month use of real-time continuous glucose monitoring in patients with type 1 diabetes: a multicenter study in Greece.

Eleftheriadou I, Didangelos T, Pappas AC, Anastasiou E, Vasilopoulos C, Zoupas C, Manes C, Tsatsoulis A, Benroubi M, Pangalos E, Thomakos P, Gerasimidi-Vazeou A, Tentolouris N.

Hormones (Athens). 2019 Dec;18(4):443-450. doi: 10.1007/s42000-019-00153-1. Epub 2019 Nov 13.

PMID:
31721132
6.

SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects.

Tentolouris A, Vlachakis P, Tzeravini E, Eleftheriadou I, Tentolouris N.

Int J Environ Res Public Health. 2019 Aug 17;16(16). pii: E2965. doi: 10.3390/ijerph16162965. Review.

7.

Management of diabetes mellitus and patients' attitude towards the disease: Data from a nationwide study in Greece.

Tentolouris A, Eleftheriadou I, Tzeravini E, Athanasakis K, Anastasiou IA, Kyriopoulos J, Tentolouris N.

Diabetes Metab Syndr. 2019 Mar - Apr;13(2):1159-1164. doi: 10.1016/j.dsx.2019.01.030. Epub 2019 Jan 26.

PMID:
31336459
8.

Advancing pharmacotherapy for diabetic foot ulcers.

Eleftheriadou I, Tentolouris A, Tentolouris N, Papanas N.

Expert Opin Pharmacother. 2019 Jun;20(9):1153-1160. doi: 10.1080/14656566.2019.1598378. Epub 2019 Apr 8. Review.

PMID:
30958725
9.

Endothelium as a Therapeutic Target in Diabetes Mellitus: From Basic Mechanisms to Clinical Practice.

Tentolouris A, Eleftheriadou I, Tzeravini E, Tsilingiris D, Paschou SA, Siasos G, Tentolouris N.

Curr Med Chem. 2020;27(7):1089-1131. doi: 10.2174/0929867326666190119154152.

PMID:
30663560
10.

Low prevalence of rheumatoid arthritis among patients with pre-existing type 2 diabetes mellitus.

Tentolouris A, Thanopoulou A, Tentolouris N, Eleftheriadou I, Voulgari C, Andrianakos A, Sfikakis PP.

Ann Transl Med. 2018 Oct;6(20):399. doi: 10.21037/atm.2018.09.14.

11.

The association of diabetic microvascular and macrovascular disease with cutaneous circulation in patients with type 2 diabetes mellitus.

Eleftheriadou I, Tentolouris A, Grigoropoulou P, Tsilingiris D, Anastasiou I, Kokkinos A, Perrea D, Katsilambros N, Tentolouris N.

J Diabetes Complications. 2019 Feb;33(2):165-170. doi: 10.1016/j.jdiacomp.2018.10.008. Epub 2018 Oct 12.

PMID:
30446479
12.

Effect of 12-month intervention with low-dose atorvastatin on pulse wave velocity in subjects with type 2 diabetes and dyslipidaemia.

Grigoropoulou P, Tentolouris A, Eleftheriadou I, Tsilingiris D, Vlachopoulos C, Sykara M, Tentolouris N.

Diab Vasc Dis Res. 2019 Jan;16(1):38-46. doi: 10.1177/1479164118805320. Epub 2018 Oct 17.

PMID:
30328360
13.

Plasma Irisin Levels in Subjects with Type 1 Diabetes: Comparison with Healthy Controls.

Tentolouris A, Eleftheriadou I, Tsilingiris D, Anastasiou IA, Kosta OA, Mourouzis I, Kokkinos A, Pantos C, Katsilambros N, Tentolouris N.

Horm Metab Res. 2018 Nov;50(11):803-810. doi: 10.1055/a-0748-6170. Epub 2018 Oct 4.

PMID:
30286484
14.

Diabetic Foot Infections: Update on Management.

Nikoloudi M, Eleftheriadou I, Tentolouris A, Kosta OA, Tentolouris N.

Curr Infect Dis Rep. 2018 Aug 1;20(10):40. doi: 10.1007/s11908-018-0645-6. Review.

PMID:
30069605
15.

The Effect of the Oral Administration of Leucine on Endothelial Function, Glucose and Insulin Concentrations in Healthy Subjects.

Argyrakopoulou G, Kontrafouri P, Eleftheriadou I, Kokkinos A, Arapostathi C, Kyriaki D, Perrea D, Revenas C, Katsilambros N, Tentolouris N.

Exp Clin Endocrinol Diabetes. 2019 Sep;127(8):505-510. doi: 10.1055/a-0597-8985. Epub 2018 Jun 11.

PMID:
29890542
16.

Pulse pressure amplification and cardiac autonomic dysfunction in patients with type 2 diabetes mellitus.

Eleftheriadou I, Drosos GC, Tentolouris A, Konstantonis G, Sfikakis PP, Protogerou AD, Tentolouris N.

J Hum Hypertens. 2018 Sep;32(8-9):531-539. doi: 10.1038/s41371-018-0070-1. Epub 2018 May 23.

PMID:
29789692
17.

Prevalence of diabetes mellitus as well as cardiac and other main comorbidities in a representative sample of the adult Greek population in comparison with the general population.

Tentolouris A, Eleftheriadou I, Athanasakis K, Kyriopoulos J, Tsilimigras DI, Grigoropoulou P, Doupis J, Tentolouris N.

Hellenic J Cardiol. 2018 May 3. pii: S1109-9666(18)30038-1. doi: 10.1016/j.hjc.2018.04.008. [Epub ahead of print]

18.

Insulin degludec U100 is associated with lower risk for severe and symptomatic hypoglycemia as compared with insulin glargine U100 in subjects with type 1 diabetes.

Tentolouris A, Eleftheriadou I, Tentolouris N.

Ann Transl Med. 2018 Feb;6(3):63. doi: 10.21037/atm.2017.12.28. No abstract available.

19.

Effect of α-lipoic acid on symptoms and quality of life in patients with painful diabetic neuropathy.

Agathos E, Tentolouris A, Eleftheriadou I, Katsaouni P, Nemtzas I, Petrou A, Papanikolaou C, Tentolouris N.

J Int Med Res. 2018 May;46(5):1779-1790. doi: 10.1177/0300060518756540. Epub 2018 Mar 8.

20.

Liver cirrhosis-effect on QT interval and cardiac autonomic nervous system activity.

Tsiompanidis E, Siakavellas SI, Tentolouris A, Eleftheriadou I, Chorepsima S, Manolakis A, Oikonomou K, Tentolouris N.

World J Gastrointest Pathophysiol. 2018 Feb 15;9(1):28-36. doi: 10.4291/wjgp.v9.i1.28.

21.

Diabetes mellitus doubles the risk of type 2 cardiorenal syndrome: results from the NHANES trial.

Tentolouris N, Eleftheriadou I.

Hellenic J Cardiol. 2017 Sep - Oct;58(5):348-349. doi: 10.1016/j.hjc.2017.11.013. Epub 2017 Dec 1. No abstract available.

22.

Cardiac Autonomic Neuropathy Predicts All-Cause and Cardiovascular Mortality in Patients With End-Stage Renal Failure: A 5-Year Prospective Study.

Doulgerakis D, Moyssakis I, Kapelios CJ, Eleftheriadou I, Chorepsima S, Michail S, Tentolouris N.

Kidney Int Rep. 2017 Mar 16;2(4):686-694. doi: 10.1016/j.ekir.2017.03.002. eCollection 2017 Jul.

23.

Antidiabetic Drugs as Antihypertensives: New Data on the Horizon.

Mamakou V, Eleftheriadou I, Katsiki N, Makrilakis K, Tsioufis K, Tentolouris N.

Curr Vasc Pharmacol. 2017;16(1):70-78. doi: 10.2174/1570161115666171010122332. Review.

PMID:
29032756
24.

The association between pulse wave velocity and peripheral neuropathy in patients with type 2 diabetes mellitus.

Tentolouris A, Eleftheriadou I, Grigoropoulou P, Kokkinos A, Siasos G, Ntanasis-Stathopoulos I, Tentolouris N.

J Diabetes Complications. 2017 Nov;31(11):1624-1629. doi: 10.1016/j.jdiacomp.2017.07.010. Epub 2017 Jul 27.

PMID:
28893495
25.

Update on Cardiovascular Effects of Older and Newer Anti-diabetic Medications.

Eleftheriadou I, Grigoropoulou P, Liberopoulos E, Liatis S, Kokkinos A, Tentolouris N.

Curr Med Chem. 2018;25(13):1549-1566. doi: 10.2174/0929867324666170530075533. Review.

PMID:
28554326
26.

Pulse wave velocity and cardiac autonomic function in type 2 diabetes mellitus.

Chorepsima S, Eleftheriadou I, Tentolouris A, Moyssakis I, Protogerou A, Kokkinos A, Sfikakis PP, Tentolouris N.

BMC Endocr Disord. 2017 May 19;17(1):27. doi: 10.1186/s12902-017-0178-2.

27.

Selective transduction of astrocytic and neuronal CNS subpopulations by lentiviral vectors pseudotyped with Chikungunya virus envelope.

Eleftheriadou I, Dieringer M, Poh XY, Sanchez-Garrido J, Gao Y, Sgourou A, Simmons LE, Mazarakis ND.

Biomaterials. 2017 Apr;123:1-14. doi: 10.1016/j.biomaterials.2017.01.023. Epub 2017 Jan 23.

28.

Diabetic Foot Infections: an Update in Diagnosis and Management.

Grigoropoulou P, Eleftheriadou I, Jude EB, Tentolouris N.

Curr Diab Rep. 2017 Jan;17(1):3. doi: 10.1007/s11892-017-0831-1. Review.

PMID:
28101794
29.

Association of plasma fetuin-a levels with peripheral arterial disease and lower extremity arterial calcification in subjects with type 2 diabetes mellitus.

Eleftheriadou I, Grigoropoulou P, Kokkinos A, Mourouzis I, Perrea D, Katsilambros N, Sfikakis PP, Tentolouris N.

J Diabetes Complications. 2017 Mar;31(3):599-604. doi: 10.1016/j.jdiacomp.2016.11.006. Epub 2016 Nov 12.

PMID:
27899247
30.

PPARγ-coactivator-1α gene transfer reduces neuronal loss and amyloid-β generation by reducing β-secretase in an Alzheimer's disease model.

Katsouri L, Lim YM, Blondrath K, Eleftheriadou I, Lombardero L, Birch AM, Mirzaei N, Irvine EE, Mazarakis ND, Sastre M.

Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):12292-12297. Epub 2016 Oct 10.

31.

αCAR IGF-1 vector targeting of motor neurons ameliorates disease progression in ALS mice.

Eleftheriadou I, Manolaras I, Irvine EE, Dieringer M, Trabalza A, Mazarakis ND.

Ann Clin Transl Neurol. 2016 Sep 7;3(10):752-768. eCollection 2016 Oct.

32.

The effect of consumption of low-glycemic-index and low-glycemic-load desserts on anthropometric parameters and inflammatory markers in patients with type 2 diabetes mellitus.

Argiana V, Kanellos PΤ, Makrilakis K, Eleftheriadou I, Tsitsinakis G, Kokkinos A, Perrea D, Tentolouris N.

Eur J Nutr. 2015 Oct;54(7):1173-80. doi: 10.1007/s00394-014-0795-8. Epub 2014 Dec 5.

PMID:
25475658
33.

Dry eye syndrome in subjects with diabetes and association with neuropathy.

Achtsidis V, Eleftheriadou I, Kozanidou E, Voumvourakis KI, Stamboulis E, Theodosiadis PG, Tentolouris N.

Diabetes Care. 2014 Oct;37(10):e210-1. doi: 10.2337/dc14-0860. No abstract available.

PMID:
25249675
34.

A patient with type 2 diabetes and a burning sensation in his feet.

Eleftheriadou I, Tentolouris N, Jude EB.

BMJ. 2014 Jul 31;349:g4658. doi: 10.1136/bmj.g4658. No abstract available.

PMID:
25081249
35.

Pathogenesis and treatment of impaired wound healing in diabetes mellitus: new insights.

Baltzis D, Eleftheriadou I, Veves A.

Adv Ther. 2014 Aug;31(8):817-36. doi: 10.1007/s12325-014-0140-x. Epub 2014 Jul 29. Review.

PMID:
25069580
36.

Rabies virus envelope glycoprotein targets lentiviral vectors to the axonal retrograde pathway in motor neurons.

Hislop JN, Islam TA, Eleftheriadou I, Carpentier DC, Trabalza A, Parkinson M, Schiavo G, Mazarakis ND.

J Biol Chem. 2014 Jun 6;289(23):16148-63. doi: 10.1074/jbc.M114.549980. Epub 2014 Apr 21.

37.

Specific retrograde transduction of spinal motor neurons using lentiviral vectors targeted to presynaptic NMJ receptors.

Eleftheriadou I, Trabalza A, Ellison SM, Gharun K, Mazarakis ND.

Mol Ther. 2014 Jul;22(7):1285-1298. doi: 10.1038/mt.2014.49. Epub 2014 Mar 26.

38.

Enhanced central nervous system transduction with lentiviral vectors pseudotyped with RVG/HIV-1gp41 chimeric envelope glycoproteins.

Trabalza A, Eleftheriadou I, Sgourou A, Liao TY, Patsali P, Lee H, Mazarakis ND.

J Virol. 2014 Mar;88(5):2877-90. doi: 10.1128/JVI.03376-13. Epub 2013 Dec 26.

39.

Diabetes treatment: recent developments.

Veves A, Baltzis D, Eleftheriadou I.

Adv Ther. 2013 Dec;30(12):1031-2. doi: 10.1007/s12325-013-0073-9. No abstract available.

40.

Effect of atorvastatin on baroreflex sensitivity in subjects with type 2 diabetes and dyslipidaemia.

Grigoropoulou P, Eleftheriadou I, Zoupas C, Makrilakis K, Papassotiriou I, Margeli A, Perrea D, Katsilambros N, Tentolouris N.

Diab Vasc Dis Res. 2014 Jan;11(1):26-33. doi: 10.1177/1479164113508293. Epub 2013 Oct 23.

PMID:
24154932
41.

Vesicular stomatitis virus glycoprotein- and Venezuelan equine encephalitis virus-derived glycoprotein-pseudotyped lentivirus vectors differentially transduce corneal endothelium, trabecular meshwork, and human photoreceptors.

Lipinski DM, Barnard AR, Charbel Issa P, Singh MS, De Silva SR, Trabalza A, Eleftheriadou I, Ellison SM, Mazarakis ND, MacLaren RE.

Hum Gene Ther. 2014 Jan;25(1):50-62. doi: 10.1089/hum.2013.009. Epub 2013 Dec 21.

PMID:
24125177
42.

Incretin-based therapies for type 2 diabetes mellitus: effects on insulin resistance.

Grigoropoulou P, Eleftheriadou I, Zoupas C, Diamanti-Kandarakis E, Tentolouris N.

Curr Diabetes Rev. 2013 Sep;9(5):412-7. Review.

PMID:
23855508
43.

The effect of hyperhomocysteinemia on aortic distensibility in healthy individuals.

Eleftheriadou I, Grigoropoulou P, Moyssakis I, Kokkinos A, Perrea D, Toutouzas K, Katsilambros N, Tentolouris N.

Nutrition. 2013 Jun;29(6):876-80. doi: 10.1016/j.nut.2012.12.026. Epub 2013 Feb 21.

PMID:
23434109
44.

Venezuelan equine encephalitis virus glycoprotein pseudotyping confers neurotropism to lentiviral vectors.

Trabalza A, Georgiadis C, Eleftheriadou I, Hislop JN, Ellison SM, Karavassilis ME, Mazarakis ND.

Gene Ther. 2013 Jul;20(7):723-32. doi: 10.1038/gt.2012.85. Epub 2012 Nov 22.

PMID:
23171919
45.

Advances in the topical treatment of diabetic foot ulcers.

Papanas N, Eleftheriadou I, Tentolouris N, Maltezos E.

Curr Diabetes Rev. 2012 May;8(3):209-18. Review.

PMID:
22429013
46.

The role of the osteoprotegerin/RANKL/RANK system in diabetic vascular disease.

Grigoropoulou P, Eleftheriadou I, Zoupas C, Tentolouris N.

Curr Med Chem. 2011;18(31):4813-9. Review.

PMID:
21919846
47.

Screening for the high-risk foot of ulceration: tests of somatic and autonomic nerve function.

Argiana V, Eleftheriadou I, Tentolouris N.

Curr Diab Rep. 2011 Aug;11(4):294-301. doi: 10.1007/s11892-011-0192-0. Review.

PMID:
21494779
48.

Choice of antihypertensive treatment in subjects with pre-diabetes. Is there a dream after the navigator.

Eleftheriadou I, Tsioufis C, Tsiachris D, Tentolouris N, Stefanadis C.

Curr Vasc Pharmacol. 2011 Nov;9(6):715-22. Review.

PMID:
21470107
49.

Methicillin-resistant Staphylococcus aureus in diabetic foot infections.

Eleftheriadou I, Tentolouris N, Argiana V, Jude E, Boulton AJ.

Drugs. 2010 Oct 1;70(14):1785-97. doi: 10.2165/11538070-000000000-00000. Review.

PMID:
20836573
50.

Acute hyperhomocysteinemia impairs endothelium function in subjects with type 2 diabetes mellitus.

Doupis J, Eleftheriadou I, Kokkinos A, Perrea D, Pavlatos S, Gonis A, Katsilambros N, Tentolouris N.

Exp Clin Endocrinol Diabetes. 2010 Jul;118(7):453-8. doi: 10.1055/s-0030-1248290. Epub 2010 Mar 3.

PMID:
20200816

Supplemental Content

Loading ...
Support Center